Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
Semaglutide vs. tirzepatide: which weight loss medication is right for you? Both are GLP-1 receptor agonists that mimic appetite-regulating hormones, but tirzepatide also targets GIP receptors, offering greater average weight loss and additional metabolic benefits. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) both require a prescription, medical supervision, and lifestyle changes like improved diet and exercise.
Key factors to weigh include your medical history, tolerance for side effects (nausea, GI issues), dosing schedules, cost, and insurance coverage. Because efficacy, safety monitoring, and pricing vary significantly between the two, the "right" choice depends on your individual health profile.
Not sure whether your symptoms or weight-related concerns point to a condition these medications could help address? Take a free, instant, online symptom check to better understand what's going on inside your body and get personalized guidance on your next steps. In just a few minutes, you'll have clearer insight into whether speaking with a doctor about GLP-1 options makes sense for you—no signup, no cost, no pressure.
Reviewed for medical accuracy: 07/10/2026
If you've tried diet and exercise without the lasting results you hoped for, you're not alone. Prescription medications like semaglutide and tirzepatide have emerged as powerful tools for those facing obesity or struggling to lose weight. Below, we'll walk through how each works, compare their benefits and drawbacks, and outline the next steps you can take—safely and effectively.
Both semaglutide and tirzepatide mimic hormones that help regulate appetite, blood sugar, and digestion. Here's what sets them apart:
Clinical trials have shown both drugs can produce significant weight loss when combined with lifestyle changes. Here's a snapshot of the numbers:
| Metric | Semaglutide (Wegovy) | Tirzepatide (Mounjaro) |
|---|---|---|
| Average weight loss | 10–17% of body weight¹ | 15–20% of body weight² |
| Time to peak effect | ~16–20 weeks | ~20–28 weeks |
| HbA1c reduction (in T2D) | 1.5–2% | 2–2.5% |
¹ Source: STEP trials; ² Source: SURPASS trials.
Individual results may vary.
No medication is side-effect free. Understanding the typical reactions can help you set realistic expectations:
The cost of semaglutide and tirzepatide varies widely. Here's what to consider:
Ask your pharmacy or doctor to help navigate insurance prior authorizations.
Medications amplify—but don't replace—lifestyle changes. For best outcomes, integrate:
Before you start semaglutide, tirzepatide, or any prescription, it's wise to get a thorough check-in on your health. If you're experiencing any symptoms or want to better understand your personal health profile before pursuing weight-loss medications, take Ubie's free AI Symptom Checker to receive personalized insights that can help inform your conversation with a healthcare provider.
When choosing between semaglutide vs tirzepatide, talk with your healthcare provider about:
Your doctor can help you weigh these factors and tailor a plan that fits your unique profile.
Once you start treatment:
While semaglutide and tirzepatide are generally safe under medical supervision, always:
Weight loss can feel overwhelming, but modern therapies like semaglutide vs tirzepatide offer new hope when traditional methods fall short. By combining:
you can improve your chances of lasting success without unnecessary risks or anxiety. Take the first step by using an AI-powered Symptom Checker to better understand your current health status and any underlying conditions that might affect your weight-loss journey, then speak to a doctor to explore whether semaglutide or tirzepatide is right for you.
Your journey to better health starts with informed choices and trusted medical guidance. Good luck—and remember, you don't have to go it alone.
(References)
* O'Neil PM, Aroda VR, et al. Tirzepatide and Semaglutide: A Narrative Review of Their Efficacy and Safety in Treating Obesity. Diabetes Obes Metab. 2024 Apr;26(4):681-692. doi: 10.1111/dom.15410. Epub 2024 Feb 5. PMID: 38314120.
* Singh M, Gupta V, et al. Semaglutide and Tirzepatide for Weight Loss: A Systematic Review and Meta-Analysis. Cureus. 2023 Dec 10;15(12):e49987. doi: 10.7759/cureus.49987. PMID: 38205499; PMCID: PMC10780287.
* Kim J, Heo E, et al. Semaglutide versus Tirzepatide for the Treatment of Obesity: A Comprehensive Review. J Clin Med. 2024 Feb 29;13(5):1377. doi: 10.3390/jcm13051377. PMID: 38435163; PMCID: PMC10931551.
* Dhaliwal K, Singal D, et al. Comparing the Effects of Tirzepatide and Semaglutide on Body Weight, Glucose Control, and Cardiovascular Outcomes: A Review. Cureus. 2023 Dec 5;15(12):e49929. doi: 10.7759/cureus.49929. PMID: 38171064; PMCID: PMC10769387.
* Blak BT, Tchang BG, et al. Tirzepatide: a dual GLP-1 and GIP receptor agonist for the treatment of type 2 diabetes with significant weight loss effects. Expert Opin Investig Drugs. 2022 Mar;31(3):215-226. doi: 10.1080/13543784.2022.2030225. Epub 2022 Jan 28. PMID: 35092067.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.